未登录 分享 收藏
Laser-based mid-IR spectroscopy as a rapid analytical technique for the quantification of human milk proteins 基于激光的中红外光谱法作为快速分析人乳蛋白质含量的技术 Ten-Domenech, Isabel; Vijayakumar, Shilpa; Schwaighofer, Andreas; Ramer, Georg; Van den Oever, Sabrina P.; Moreno-Gimenez, Alba; Parra-Llorca, Anna; Vaya, Maria J.; Gormaz, Maria; Mayer, Helmut K.; Quintas, Guillermo; Kuligowski, Julia; Lendl, Bernhard 分享 收藏
分享 收藏
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy Short, Nicholas J.; Benton, Christopher B.; Chen, Hsiang-Chun; Qiu, Peng; Gu, Lisa; Pierce, Sherry; Brandt, Mark; Maiti, Abhishek; Min, Taejin L.; Naqvi, Kiran; Quintas-Cardama, Alfonso; Konopleva, Marina; Kadia, Tapan; Cortes, Jorge; Garcia-Manero, Guillermo; Ravandi, Farhad; Jabbour, Elias; Kantarjian, Hagop; Andreeff, Michael 分享 收藏
p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL Lee, H. J.; Gallardo, M.; Ma, H.; Zhang, X.; Larsson, C. A.; Mejia, A.; Hornbaker, M. J.; Qi, Y.; Su, X.; Pageon, L. R.; Quintas-Cardama, A.; Post, S. M. 分享 收藏
分享 收藏
Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib Olshen, Adam; Tang, Min; Cortes, Jorge; Gonen, Mithat; Hughes, Timothy; Branford, Susan; Quintas-Cardama, Alfonso; Michor, Franziska 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Polymutant BCR-ABL1 proteins during chronic myeloid leukemia therapy: Novel mechanisms of resitance from clinical, in vitro, and in silico evidence. Pricl, Sabrina; Gibbons, Don L.; Posoccol, Paola; Laurini, Erik; Giabba, Barbara; Storici, Paola; Fermeglial, Maurizio; Sun, Hunshi; Cortes, Jorge; Talpaz, Moshe; Donato, Nicholas; Quintas-Cardama, Alfonso 分享 收藏
HCVAD Plus Imatinib or Dasatinib in Lymphoid Blastic Phase Chronic Myeloid Leukemia Strati, Paolo; Kantarjian, Hagop; Thomas, Deborah; O'Brien, Susan; Konoplev, Sergej; Jorgensen, Jeffrey L.; Luthra, Raja; Abruzzo, Lynne; Jabbour, Elias; Quintas-Cardama, Alfonso; Borthakur, Gautam; Faderl, Stefan; Ravandi, Farhad; Cortes, Jorge 分享 收藏
Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors Falchi, Lorenzo; Kantarjian, Hagop M.; Wang, Xuemei; Verma, Dushyant; Quintas-Cardama, Alfonso; O'Brien, Susan; Jabbour, Elias J.; Ravandi-Kashani, Farhad; Borthakur, Gautam; Garcia-Manero, Guillermo; Verstovsek, Srdan; Burger, Jan A.; Luthra, Raja; Cortes, Jorge E. 分享 收藏
分享 收藏
Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months Nazha, Aziz; Kantarjian, Hagop; Jain, Preetesh; Romo, Carlos; Jabbour, Elias; Quintas-Cardama, Alfonso; Luthra, Raja; Abruzzo, Lynne; Borthakur, Gautam; Ravandi, Farhad; Pierce, Sherry; O'Brien, Susan; Cortes, Jorge 分享 收藏
分享 收藏
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia Kantarjian, Hagop M.; Martinelli, Giovanni; Jabbour, Elias J.; Quintas-Cardama, Alfonso; Ando, Kiyoshi; Bay, Jacques-Olivier; Wei, Andrew; Groepper, Stefanie; Papayannidis, Cristina; Owen, Kate; Pike, Laura; Schmitt, Nicola; Stockman, Paul K.; Giagounidis, Aristoteles 分享 收藏
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome Al-Kali, Aref; Quintas-Cardama, Alfonso; Luthra, Raja; Bueso-Ramos, Carlos; Pierce, Sherry; Kadia, Tapan; Borthakur, Gautam; Estrov, Zeev; Jabbour, Elias; Faderl, Stefan; Ravandi, Farhad; Cortes, Jorges; Tefferi, Ayalew; Kantarjian, Hagop; Garcia-Manero, Guillermo 分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
